Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Navitar Life Sciences Inc.

Facebook Twitter LinkedIn Email Comments
Navitar Life Sciences Inc., an affiliated entity of optics manufacturer Navitar Inc. of Rochester, N.Y., has agreed to acquire the assets of Modulation Optics, including its Hoffman Modulation Contrast (HMC) imaging technology. The Glen Cove, N.Y., company makes HMC microscope components and systems for use in live-cell imaging applications such as stem cell imaging, cancer studies, and embryo and sperm monitoring during in vitro fertilization procedures. The technology is used to view colorless and transparent biological specimens. The acquisition enables Navitar to expand its product offering beyond its mainstay ZFL fluorescence imaging optical systems. HMC will now be used in combination with Navitar’s other illumination techniques, such as differential interference contrast, dark field, bright field and fluorescence to achieve high-quality images. HMC can be applied to most objective lenses.


BioPhotonics
Sep 2011
AmericasBiophotonicsBusinessdifferential interference contrastHoffman Modulation ContrastimagingJeremy GoldsteinJulian GoldsteinLeicalenseslive-cell imagingMicroscopyModulation OpticsNavitar Inc.Navitar Life Sciences Inc.New YorkNikonOlympusopticsOptics ManufacturingRapidScanRobert HoffmanZeiss

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.